An NBCF-funded study has shown that new tool, the IHC4+C score, can be used to provide prognostic information for women considering chemotherapy.
Skip to Content
Skip to Navigation
You have returned to the top of the page.
New pilot study helps spare low-risk patients from chemotherapy
